Episode Details
Back to Episodes
Canada Approves 2nd Generic Ozempic, Prices Drop
Published 2 weeks ago
Description
Health Canada approves second generic Ozempic, a semaglutide injection for type 2 diabetes and weight loss, from Apotex. Canada becomes the first G7 nation to greenlight these generics, potentially lowering prices by 50% with increased competition. New studies highlight semaglutides benefits beyond diabetes, but doctors warn of potential side effects if misused. Stay tuned for more generics to improve access.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/9d5e47d4ea3cfa74